Senior living operators increasingly adopting green initiatives: Ziegler
By
Kimberly Bonvissuto
Mar 17, 2023
If senior living operators don’t already have electric vehicle charging stations at their communities, they’re thinking about adding them, according to the results of the latest Ziegler CFO Hotline...
Proposed legislation would dedicate $5 million for telemedicine infrastructure for assisted living, nursing...
By
Kimberly Bonvissuto
Feb 13, 2024
Expanding access to telehealth is the goal of a proposed bill in South Dakota that would provide millions in funding for assisted living communities and nursing homes across the state to implement telemedicine...
Employers should tread carefully in maintaining pandemic-era practices, EEOC says
By
Kimberly Bonvissuto
May 17, 2023
The COVID-19 public health emergency is over, but employers can continue implementing many pandemic-era practices, according to the US Equal Employment Opportunity Commission.
Older adults at risk for dementia see fast declines in household wealth before dementia onset
By
Kimberly Bonvissuto
Sep 19, 2023
Household wealth, especially financial wealth, declines much more quickly among people with probable dementia in the decade before dementia onset compared with older adults without a dementia diagnosis,...
FDA approval of new COVID-19 boosters could come by Friday
Sep 07, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Bake sale-supported nursing home turns to assisted living to survive
By
Josh Henreckson
Apr 05, 2024
A Rhode Island nursing home that had turned to a grassroots funding campaign that included a resident-run bake sale to avoid closure is reworking one of its floors into a memory-care focused assisted...
FDA approves Voquezna for erosive esophagitis, GERD
Nov 07, 2023
A Phase 3 trial showed noninferiority versus lansoprazole in healing and maintenance phases.
New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
K4Connect raises $8.9M from investors in latest funding round
By
Kathleen Steele Gaivin
Jul 17, 2023
Morrisville, NC-based K4Connect has raised $8.9 million from 14 investors, according to a Thursday filing with the Securities and Exchange Commiss
Tennessee creates coordinated response to Alzheimer’s disease
By
Kimberly Bonvissuto
Apr 26, 2024
Recognizing the need to coordinate and integrate services for older adults and people with disabilities, Tennessee has created a new Department of Aging and Disability to provide more strategic planning...